Skip to main content
SpringerLink
Log in

Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study

  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

Background/Purpose

The prognosis of hepatocellular carcinoma (HCC) with tumor thrombosis of the main trunk or major branches of the portal vein (mPVTT) is extremely poor, even if it is curatively resected. Uncontrollable multiple metastases to the residual liver are often observed within several months after the operation. We report here the results of a pilot study, showing the efficacy of adjuvant arterial infusion chemotherapy after the resection of HCC with mPVTT.

Methods

Twelve patients had curative resection of HCC with mPVTT. Six of the patients were treated by the arterial infusion of a chemotherapeutic agent via a subcutaneously implanted injection port after curative resection of HCC with mPVTT. The initial course consisted of the daily administration of cisplatin (CDDP) and continuous infusion of 5-fluorouracil (5-FU). This was followed by the weekly or biweekly administration of CDDP and subsequent infusion of 5-FU until the cumulative dose of 5-FU reached 15 g.

Results

The median overall survival time was 58.0 months with adjuvant chemotherapy and 8.0 months without adjuvant chemotherapy. The median disease-free interval was 15.0 months with adjuvant chemotherapy and 4.0 months without adjuvant chemotherapy. Adverse reactions were tolerable nausea and loss of appetite.

Conclusions

This chemotherapeutic regimen achieved favorable results and may be useful as adjuvant chemotherapy in treating patients after curative resection of HCC with mPVTT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E Ando F Yamashita M Tanaka K Tanikawa (1997) ArticleTitleA novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein Cancer 79 1890–1896 Occurrence Handle1:CAS:528:DyaK2sXjtlerurc%3D Occurrence Handle9149014

    CAS  PubMed  Google Scholar 

  2. K Okuda T Ohtsuki H Obata M Tomimatsu N Okazaki H Hasegawa Y Nakajima K Ohnishi (1985) ArticleTitleNatural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56 918–928 Occurrence Handle1:STN:280:BiqB2MvivFE%3D

    CAS  Google Scholar 

  3. InstitutionalAuthorNameThe Liver Cancer Study Group of Japan (1994) ArticleTitlePredictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan Cancer 74 2772–2780

    Google Scholar 

  4. B Cady (1983) ArticleTitleNatural history of primary and secondary tumors of the liver Semin Oncol 10 127–134 Occurrence Handle1:STN:280:BiyB2cbis1Y%3D Occurrence Handle6306832

    CAS  PubMed  Google Scholar 

  5. JM Llovet J Bustamante A Castells R Vilana C Ayuso Mdel M Sala C Bru J Rodes J Bruix (1999) ArticleTitleNatural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 62–67 Occurrence Handle1:STN:280:DyaK1M%2FotFKrsw%3D%3D Occurrence Handle9862851

    CAS  PubMed  Google Scholar 

  6. InstitutionalAuthorNameLiver Cancer Study Group of Japan (1990) ArticleTitlePrimary liver cancer in Japan. Clinicopathologic features and results of surgical treatment Ann Surg 211 277–287

    Google Scholar 

  7. GD Dodd Suffix3rd BI Carr (1993) ArticleTitlePercutaneous biopsy of portal vein thrombus: a new staging technique for hepatocellular carcinoma AJR Am J Roentgenol 161 229–233 Occurrence Handle8392785

    PubMed  Google Scholar 

  8. S Fukuda K Okuda M Imamura I Imamura N Eriguchi S Aoyagi (2002) ArticleTitleSurgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases Surgery 131 300–310 Occurrence Handle11894035

    PubMed  Google Scholar 

  9. KE Stuart AJ Anand RL Jenkins (1996) ArticleTitleHepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival Cancer 77 2217–2222 Occurrence Handle1:STN:280:BymB38vovVE%3D Occurrence Handle8635087

    CAS  PubMed  Google Scholar 

  10. JV Sitzmann R Abrams (1993) ArticleTitleImproved survival for hepatocellular cancer with combination surgery and multimodality treatment Ann Surg 217 149–154 Occurrence Handle1:STN:280:ByyC2srpsVI%3D Occurrence Handle8382468

    CAS  PubMed  Google Scholar 

  11. K Kumada K Ozawa R Okamoto T Takayasu M Yamaguchi Y Yamamoto H Higashiyama S Morikawa H Sasaki Y Shimahara (1990) ArticleTitleHepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi Surgery 108 821–827 Occurrence Handle1:STN:280:By6D2cfktVc%3D Occurrence Handle2173162

    CAS  PubMed  Google Scholar 

  12. E Ando M Tanaka F Yamashita R Kuromatsu S Yutani K Fukumori S Sumie Y Yano K Okuda M Sata (2002) ArticleTitleHepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases Cancer 95 588–595 Occurrence Handle12209752

    PubMed  Google Scholar 

  13. M Sakon H Nagano K Dono S Nakamori K Umeshita A Yamada S Kawata Y Imai S Iijima M Monden (2002) ArticleTitleCombined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches Cancer 94 435–442 Occurrence Handle1:CAS:528:DC%2BD38XhtV2qs70%3D Occurrence Handle11900229

    CAS  PubMed  Google Scholar 

  14. InstitutionalAuthorNameEpirubicin Study Group for Hepatocellular Carcinoma (1987) ArticleTitleIntra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma Cancer Chemother Pharmacol 19 183–189

    Google Scholar 

  15. K Ishii M Sugimoto S Matsuki S Matama H Shibata S Kusano (1992) ArticleTitleIs necrosis induction therapy relevant to hepatocellular carcinoma? Prognostic evaluation viewed from necrosing feature in HCC occluding the main portal vein after treatment with DBcAMP and MMC Am J Gastroenterol 87 118–123 Occurrence Handle1:STN:280:By2D1Mris1I%3D Occurrence Handle1309405

    CAS  PubMed  Google Scholar 

  16. KJ Scanlon EM Newman Y Lu DG Priest (1986) ArticleTitleBiochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells Proc Natl Acad Sci USA 83 8923–8925 Occurrence Handle1:CAS:528:DyaL2sXktlKjtQ%3D%3D Occurrence Handle3466165

    CAS  PubMed  Google Scholar 

  17. T Itamoto H Nakahara H Tashiro N Haruta T Asahara A Naito K Ito (2002) ArticleTitleHepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein J Surg Oncol 80 143–148 Occurrence Handle1:CAS:528:DC%2BD38XlvFKktrY%3D Occurrence Handle12115797

    CAS  PubMed  Google Scholar 

  18. H Nakamura T Hashimoto H Oi S Sawada (1989) ArticleTitleTranscatheter oily chemoembolization of hepatocellular carcinoma Radiology 170 783–786 Occurrence Handle1:STN:280:BiaC38bjsVM%3D Occurrence Handle2536946

    CAS  PubMed  Google Scholar 

  19. R Yamada M Sato M Kawabata H Nakatsuka K Nakamura S Takashima (1983) ArticleTitleHepatic artery embolization in 120 patients with unresectable hepatoma Radiology 148 397–401 Occurrence Handle1:STN:280:BiyB2cfht1Y%3D Occurrence Handle6306721

    CAS  PubMed  Google Scholar 

  20. HS Lee JS Kim IJ Choi JW Chung JH Park CY Kim (1997) ArticleTitleThe safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study Cancer 79 2087–2094 Occurrence Handle1:STN:280:ByiA383ls1A%3D Occurrence Handle9179054

    CAS  PubMed  Google Scholar 

  21. RS Nelson R de Elizalde CD Howe (1966) ArticleTitleClinical aspects of primary carcinoma of the liver Cancer 19 533–537 Occurrence Handle1:STN:280:CCmC3s7osVE%3D Occurrence Handle4286750

    CAS  PubMed  Google Scholar 

  22. N Okazaki M Yoshino T Yoshida A Hizikata H Hasegawa (1986) ArticleTitleSystemic chemotherapy of hepatocellular carcinoma (in Japanese) Gan To Kagaku Ryoho (1986) 13 1584–1588 Occurrence Handle1:STN:280:BimB28josF0%3D

    CAS  Google Scholar 

  23. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti F Montalto M Ammatuna A Morabito L Gennari (1996) ArticleTitleLiver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693–699 Occurrence Handle1:STN:280:BymC2srhs1E%3D Occurrence Handle8594428

    CAS  PubMed  Google Scholar 

  24. J McPeake R Williams (1995) ArticleTitleLiver transplantation for hepatocellular carcinoma Gut 36 644–646 Occurrence Handle1:STN:280:ByqA3MjmsVU%3D Occurrence Handle7797109

    CAS  PubMed  Google Scholar 

  25. A Tanaka T Morimoto Y Yamaoka (1996) ArticleTitleImplications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein Hepatogastroenterology 43 637–643 Occurrence Handle1:STN:280:BymA1M3mt1Q%3D Occurrence Handle8799408

    CAS  PubMed  Google Scholar 

  26. Y Yamaoka K Kumada K Ino T Takayasu Y Shimahara K Mori A Tanaka T Morimoto Y Taki M Washida et al. (1992) ArticleTitleLiver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein World J Surg 16 1172–1176 Occurrence Handle1:STN:280:ByyD1cfotlY%3D Occurrence Handle1333683

    CAS  PubMed  Google Scholar 

  27. A Tanaka T Morimoto N Ozaki I Ikai Y Yamamoto S Tsunekawa T Kitai Y Yamaoka (1996) ArticleTitleExtension of surgical indication for advanced hepatocellular carcinoma: is it possible to prolong life span or improve quality of life? Hepatogastroenterology 43 1172–1181 Occurrence Handle1:STN:280:ByiD28vpvFM%3D Occurrence Handle8908547

    CAS  PubMed  Google Scholar 

  28. RA Ellerby HLJr Davis FJ Ansfield G Ramirez (1974) ArticleTitlePhase I clinical trial of combined therapy with 5-FU (NSC 19893) and CIS-platinum (II) diaminedichloride (NSC 119875 Cancer 34 1005–1010 Occurrence Handle1:STN:280:CSqD383it1E%3D Occurrence Handle4607883

    CAS  PubMed  Google Scholar 

  29. MA Poon MJ O’Connell CG Moertel HS Wieand SA Cullinan LK Everson JE Krook JA Mailliard JA Laurie LK Tschetter (1989) ArticleTitleBiochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma J Clin Oncol 7 1407–1418 Occurrence Handle1:STN:280:BiaA1c7ns1E%3D Occurrence Handle2476530

    CAS  PubMed  Google Scholar 

  30. H Kamiyama N Toyama Y Mori K Miyazaki M Nagano S Yamada Y Suminaga F Konishi (2002) ArticleTitleResection of hepatocellular carcinoma with tumor thrombus of the portal vein after neoadjuvant regional chemotherapy J Hepatobiliary Pancreat Surg 9 759–763 Occurrence Handle12658413

    PubMed  Google Scholar 

  31. YZ Patt C Charnsangavej B Yoffe R Smith D Lawrence V Chuang H Carrasco M Roh J Chase H Fischer (1994) ArticleTitleHepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival J Clin Oncol 12 1204–1211 Occurrence Handle1:STN:280:ByuB28%2Fis1M%3D Occurrence Handle8201383

    CAS  PubMed  Google Scholar 

  32. T Urabe S Kaneko E Matsushita M Unoura K Kobayashi (1998) ArticleTitleClinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma Oncology 55 39–47 Occurrence Handle1:CAS:528:DyaK1cXovVyg Occurrence Handle9428374

    CAS  PubMed  Google Scholar 

  33. K Okuda M Tanaka J Shibata E Ando T Ogata H Kinoshita N Eriguchi S Aoyagi K Tanikawa (1999) ArticleTitleHepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment Oncol Rep 6 587–591 Occurrence Handle1:CAS:528:DyaK1MXivVGkt7Y%3D Occurrence Handle10203596

    CAS  PubMed  Google Scholar 

  34. JD Schwartz M Schwartz J Mandeli M Sung (2002) ArticleTitleNeoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials Lancet Oncol 3 593–603 Occurrence Handle12372721

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Okayama Saiseikai General Hospital, 1-17-18 Ifuku-cho, Okayama, 700-8511, Japan

    Takefumi Niguma, Tetusige Mimura & Nobumasa Tutui

Authors
  1. Takefumi Niguma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetusige Mimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobumasa Tutui
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Niguma, T., Mimura, T. & Tutui, N. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study. J Hepatobiliary Pancreat Surg 12, 249–253 (2005). https://doi.org/10.1007/s00534-004-0969-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-004-0969-5

Key words

Search

Navigation